ACIP Makes Changes to Adult RSV Vaccine Recommendations Committee ditches shared decision-making, moves to risk-based approach Jun 26, 2024
FDA Expands Use of RSV Vaccine to Include More Adults Arexvy now approved for people 50 years and older at increased risk of serious outcomes Jun 10, 2024
Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says But compared with mRNA COVID-19 vaccines, GBS was more common than expected May 31, 2024
Adult RSV Shots Given to More Than 30 Babies by Mistake "Administration errors are preventable with proper education and training," say study authors May 09, 2024
Most Expectant Moms Say They're Likely to Get Maternal RSV Vaccine But one in five soon-to-be parents said they had never even heard of RSV, survey finds Apr 25, 2024
Cardiac Events Common in Older, Hospitalized RSV Patients New RSV vaccines could reduce risk, researchers said Apr 15, 2024
Published Data Show Why GSK Bailed on Its Maternal RSV Vaccine Solid efficacy for protecting infants from serious RSV marred by 37% higher risk of preterm birth Mar 13, 2024
CDC: Nirsevimab 90% Effective Against RSV Hospitalization in Infants But effectiveness over a full RSV season expected to be lower, researchers caution Mar 08, 2024
CDC Monitoring Rare Neurologic Events After RSV Vaccination Cases of Guillain-Barre syndrome in vaccinated older adults slightly higher than background rates Feb 29, 2024
Nirsevimab Reduced Hospitalizations for Infants With RSV Monoclonal antibody is highly effective, but in short supply Dec 27, 2023
Pediatric RSV Led to Higher Hospitalization Rates Than Omicron or Flu Study underscores urgent need to use preventive measures Dec 26, 2023
Moderna's mRNA RSV Vaccine Effective in Older Adults Whether it provides lasting protection remains to be seen Dec 13, 2023
Prenatal RSV Infection Linked to Fetal Inflammation, Poorer Growth Study may give force to recommendations for maternal RSV vaccination Dec 08, 2023
Clinical Challenges: Navigating New RSV Protections for the Youngest Kids Having options is worth the extra few minutes of conversation with families, physician says Nov 10, 2023
I Lost My Baby Brother to RSV, Others Don't Have To Two new tools can prevent tens of thousands of hospitalizations and deaths Oct 16, 2023
RSV Vaccine Maintains Efficacy Across Two Seasons in Seniors And second dose after 1 year appeared to add no extra protection Oct 15, 2023
Severity of RSV Hospitalizations Rivals COVID in Older Adults Consider age, underlying medical conditions in RSV vaccine recs, researchers say Oct 05, 2023
A Framework to Communicate With Pregnant Patients About the RSV Vaccine A values-based decision-making framework is key Oct 03, 2023
CDC Advisors Endorse Maternal RSV Vax to Protect Newborns Vast majority of infants will not need monoclonal antibody if mom has received the vaccine Sep 22, 2023
Can COVID, Flu, and RSV Shots Be Given at the Same Time? Here's how experts are strategizing fall vaccines Aug 29, 2023
What to Know About New Tools to Fight RSV Two vaccines and a monoclonal antibody aim to bring down the burden of RSV Aug 23, 2023
RSV Vaccine Approved for Use in Pregnancy to Protect Infants Prescribing info has warning about the potential risk for premature birth Aug 22, 2023
CDC Advisors Back Therapeutic to Prevent RSV in Infants Unanimous support for monoclonal antibody for infants and high-risk toddlers as well Aug 03, 2023
New Drug Approved for Preventing RSV in Newborns, Tots Nirsevimab indicated for all infants, and for kids up to 2 years at high risk Jul 17, 2023
Antibody for Infant RSV Prevention to Face FDA Panel Nirsevimab shot also a possibility for some at-risk toddlers Jun 06, 2023
Second RSV Vaccine Lands Approval for Older Adults Abrysvo approved for adults 60 and up Jun 01, 2023
Second RSV Vaccine for Older Adults Gets Thumbs Up From FDA Advisors VRBPAC unanimously endorses efficacy of GSK's protein fusion vaccine, not quite as sold on safety Mar 01, 2023
FDA Panel Backs Pfizer's RSV Vaccine for Older Adults But panelists raise multiple concerns over phase III trial data Feb 28, 2023
FDA Flags Potential Guillain-Barre Risk With RSV Vaccine Candidates Both vaccines demonstrated high efficacy against symptomatic illness in large phase III trials Feb 27, 2023
RSV Vaccine Succeeds in Phase III Trial of Older Adults Here's what it could mean in practice Feb 20, 2023
Monoclonal Antibodies Linked to Reduced RSV Burden in Young Kids Meta-analysis of 14 RCTs showed significant reductions in infection, hospitalization Feb 17, 2023
Our Pediatric 'Immunity Debt' Is Really an 'RSV Debt' The virus is now collecting what it is owed Nov 29, 2022
